Home
SNSE
SNSE News

Latest Sensei Biotherapeutics Inc. (SNSE) News on November 28, 2025

Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results

GlobeNewswire

14 days ago

Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results

Sensei to ditch its lead candidate and cut workforce amidst strategic review

Pharmaceutical Technology

a month ago

Sensei to ditch its lead candidate and cut workforce amidst strategic review

Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value

GlobeNewswire

a month ago

Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value

Sensei Biotherapeutics Reports New Clinical Results Highlighting Durable Progression Free Survival Data for Solnerstotug in PD-(L)1 Resistant Tumors at the ESMO Congress 2025

GlobeNewswire

a month ago

Sensei Biotherapeutics Reports New Clinical Results Highlighting Durable Progression Free Survival Data for Solnerstotug in PD-(L)1 Resistant Tumors at the ESMO Congress 2025

MT Newswires

5 months ago

Sensei Biotherapeutics to Implement 1-for-20 Reverse Stock Split

Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split

GlobeNewswire

5 months ago

Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split

Sensei Biotherapeutics Reports First Quarter 2025 Financial Results and Updates on Clinical Progress

GlobeNewswire

7 months ago

Sensei Biotherapeutics Reports First Quarter 2025 Financial Results and Updates on Clinical Progress

Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference

GlobeNewswire

8 months ago

Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference

Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress

GlobeNewswire

8 months ago

Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress

Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors

GlobeNewswire

8 months ago

Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors

What Makes Sensei Biotherapeutics (SNSE) a New Buy Stock

Zacks

10 months ago

What Makes Sensei Biotherapeutics (SNSE) a New Buy Stock

Sensei Biotherapeutics to Participate in Oppenheimer’s 35th Annual Healthcare Life Sciences Conference

GlobeNewswire

10 months ago

Sensei Biotherapeutics to Participate in Oppenheimer’s 35th Annual Healthcare Life Sciences Conference

Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones

GlobeNewswire

a year ago

Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones

Sensei Biotherapeutics to Participate in Citi’s 2024 Global Healthcare Conference

GlobeNewswire

a year ago

Sensei Biotherapeutics to Participate in Citi’s 2024 Global Healthcare Conference

Sensei Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire

a year ago

Sensei Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences

GlobeNewswire

a year ago

Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences

3 US Penny Stocks To Monitor In October 2024

Simply Wall St.

a year ago

3 US Penny Stocks To Monitor In October 2024

Sensei Biotherapeutics to Present Preclinical Data on SNS-103 at the CRI-ENCI Eighth International Immunotherapy Conference

GlobeNewswire

a year ago

Sensei Biotherapeutics to Present Preclinical Data on SNS-103 at the CRI-ENCI Eighth International Immunotherapy Conference

Sensei Biotherapeutics to Present at Upcoming Conferences

GlobeNewswire

a year ago

Sensei Biotherapeutics to Present at Upcoming Conferences

Sensei Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire

a year ago

Sensei Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Sensei Biotherapeutics to Participate in Jefferies Global Healthcare Conference

GlobeNewswire

a year ago

Sensei Biotherapeutics to Participate in Jefferies Global Healthcare Conference

Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101

GlobeNewswire

2 years ago

Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101

Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire

2 years ago

Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting

GlobeNewswire

2 years ago

Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting

Sensei Biotherapeutics to Participate in Canaccord Genuity’s Horizons in Oncology Virtual Conference

GlobeNewswire

2 years ago

Sensei Biotherapeutics to Participate in Canaccord Genuity’s Horizons in Oncology Virtual Conference

Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of VISTA within the Tumor Microenvironment

GlobeNewswire

2 years ago

Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of VISTA within the Tumor Microenvironment

Sensei Biotherapeutics to Participate in the 3rd Annual VISTA Symposium

GlobeNewswire

2 years ago

Sensei Biotherapeutics to Participate in the 3rd Annual VISTA Symposium

Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences

GlobeNewswire

2 years ago

Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences

Sensei Biotherapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights

GlobeNewswire

2 years ago

Sensei Biotherapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights

Sensei Biotherapeutics to Present at Upcoming Conferences

GlobeNewswire

2 years ago

Sensei Biotherapeutics to Present at Upcoming Conferences

Rand Capital’s Board of Directors Approves Reduction of Asset Coverage Requirement

Business Wire

2 years ago

Rand Capital’s Board of Directors Approves Reduction of Asset Coverage Requirement

Outlook (OTLK) Surges 31% on Regulatory Update for AMD Study

Zacks

2 years ago

Outlook (OTLK) Surges 31% on Regulatory Update for AMD Study

Profound Medical Announces Non-Brokered Private Placement

GlobeNewswire

2 years ago

Profound Medical Announces Non-Brokered Private Placement

Natural Grocers by Vitamin Cottage (NYSE:NGVC) Has Some Way To Go To Become A Multi-Bagger

Simply Wall St.

2 years ago

Natural Grocers by Vitamin Cottage (NYSE:NGVC) Has Some Way To Go To Become A Multi-Bagger

Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma

GlobeNewswire

2 years ago

Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma

Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference

GlobeNewswire

2 years ago

Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference

Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones

GlobeNewswire

2 years ago

Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones

OSS Joins Two Key U.S. DoD Consortiums, SCEC and SOSSEC

GlobeNewswire

2 years ago

OSS Joins Two Key U.S. DoD Consortiums, SCEC and SOSSEC

Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzer

GlobeNewswire

2 years ago

Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzer

Gilead and Compugen Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program

Business Wire

2 years ago

Gilead and Compugen Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program

Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi

Business Wire

2 years ago

Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi

BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements

GlobeNewswire

2 years ago

BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements

City Office REIT Announces Dividends for Fourth Quarter 2023

PR Newswire

2 years ago

City Office REIT Announces Dividends for Fourth Quarter 2023

IPA Announces Closing of $1.265 Million Public Offering of Common Shares

Business Wire

2 years ago

IPA Announces Closing of $1.265 Million Public Offering of Common Shares

AMAZFIT LAUNCHES NEW SPECIAL EDITIONS OF AMAZFIT BALANCE, AND PARTNERS WITH NON-PROFIT ONE TREE PLANTED TO SUPPORT REFORESTATION PROJECTS IN EUROPE

PR Newswire

2 years ago

AMAZFIT LAUNCHES NEW SPECIAL EDITIONS OF AMAZFIT BALANCE, AND PARTNERS WITH NON-PROFIT ONE TREE PLANTED TO SUPPORT REFORESTATION PROJECTS IN EUROPE

Loop Media Schedules Full Year 2023 and Fiscal Fourth Quarter Conference Call for December 12, 2023 at 5:00 p.m. ET

Business Wire

2 years ago

Loop Media Schedules Full Year 2023 and Fiscal Fourth Quarter Conference Call for December 12, 2023 at 5:00 p.m. ET

Sidoti Events, LLC's Virtual December Small-Cap Conference

ACCESSWIRE

2 years ago

Sidoti Events, LLC's Virtual December Small-Cap Conference

TRX Gold Reports Year-End 2023 Results

GlobeNewswire

2 years ago

TRX Gold Reports Year-End 2023 Results

LCNB Corp. Agrees to Acquire Eagle Financial Bancorp, Inc.

Business Wire

2 years ago

LCNB Corp. Agrees to Acquire Eagle Financial Bancorp, Inc.

Quad Releases 2023 ESG Update

Business Wire

2 years ago

Quad Releases 2023 ESG Update

BeautyHealth Announces Leadership Transition

Business Wire

2 years ago

BeautyHealth Announces Leadership Transition

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q3 2023 Earnings Call Transcript

Weak Financial Prospects Seem To Be Dragging Down Vox Royalty Corp. (TSE:VOXR) Stock

Simply Wall St.

2 years ago

Weak Financial Prospects Seem To Be Dragging Down Vox Royalty Corp. (TSE:VOXR) Stock

Business Wire

2 years ago

The ONE Group Reports Third Quarter 2023 Financial Results

Sensei Biotherapeutics Inc (SNSE) Reports Q3 2023 Financial Results

GuruFocus.com

2 years ago

Sensei Biotherapeutics Inc (SNSE) Reports Q3 2023 Financial Results

Sensei Biotherapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights

GlobeNewswire

2 years ago

Sensei Biotherapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Share on Social Networks: